Vaxxinity, Inc.
VAXX
$0.0002
-$0.0153-98.71%
OTC PK
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -38.03% | -8.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.35% | -6.81% | |||
| Operating Income | 13.35% | 6.81% | |||
| Income Before Tax | 13.34% | 5.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.34% | 5.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.34% | 5.95% | |||
| EBIT | 13.35% | 6.81% | |||
| EBITDA | 12.40% | 8.07% | |||
| EPS Basic | 13.69% | 6.15% | |||
| Normalized Basic EPS | 13.58% | 6.22% | |||
| EPS Diluted | 13.69% | 6.15% | |||
| Normalized Diluted EPS | 13.58% | 6.22% | |||
| Average Basic Shares Outstanding | 0.38% | 0.20% | |||
| Average Diluted Shares Outstanding | 0.38% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||